Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy

Conclusion.R0 resection, the goal of neoadjuvant treatment, can be achieved in 70% of patients presenting with locally advanced pancreatic cancer. The median DFS was 31 months (95% CI: 11. 3–51.1). No relationship was found with tumor size, degree of vascular involvement, carcinoembryonic antigen test (CEA), CA 19‐9, degree of tumor regression on scan, fall in CA 19‐9, or SUV on PET scan and subsequent survival.

Source: The Oncologist - January 9, 2018 Category: Cancer & Oncology Authors: William H. Sherman, Elizabeth Hecht, David Leung, Kyung Chu Tags: Chinese Edition, Clinical Trial Results, Endocrinology Source Type: research